Date: 1 December 2021, 10am EST
More than 18 million women are living with HIV worldwide and the majority are of childbearing potential.
There is a public health imperative to ensure that these women can make informed choices about the drugs they take for HIV treatment or prevention. Information to support optimal antiretroviral drug choices in pregnancy has rarely been available for women or their health providers, largely due to historically protectionist and conservative approaches to clinical studies conducted in pregnant and breastfeeding women.
Led by the World Health Organization (WHO) and the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network, a year-long Workshop was held to discuss approaches to accelerate investigation and evidence generation to inform safe use of new HIV agents in pregnant women and formulate a strategic action plan for promoting the inclusion of pregnant women in research of new HIV agents.
Thank you for joining the webinar! If you were unable to join live, you may watch the video below.
- Webinar Slides
- Approaches to Enhance and Accelerate Study of New Drugs for HIV and Associated Infections in Pregnant Women
- Research for Informed Choices: Accelerating the Study of New Drugs for HIV in Pregnant and Breastfeeding Women: A Call to Action